Exchange: NYSE·Updated 07:30 PM EST

INSP News

News
all
press releases
Inspire Medical Systems Q3 2026 Earnings Call Transcript
Inspire Medical Systems (NYSE:INSP) reported third-quarter financial results on Monday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzingaread more...
Benzinga
Inspire Medical Systems Q3 2026 Earnings Call Transcript
Inspire Medical Systems (NYSE:INSP) reported third-quarter financial results on Monday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzingaread more...
Benzinga
More News
Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
Inspire (INSP) delivered earnings and revenue surprises of +40.00% and +1.17%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Inspire Medical Systems Q3 26 Earnings Conference Call At 5:00 PM ET
(RTTNews) - Inspire Medical Systems, Inc. (INSP) will host a conference call at 5:00 PM ET on November 2, 2026, to discuss Q3 26 earnings results...
Nasdaq News: Markets
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.
Zacks
Here's How Tempus AI Demonstrates Improving Operating Leverage
TEM shows improving operating leverage as Q2 revenues jump 22%, adjusted EBITDA turns positive and lower interest costs support its free cash flow goal.
Zacks
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Mary-Katherine (Katie) McClure as Chief Commercial...
Business Wire
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.
Zacks
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
Zacks
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure
DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.
Zacks

Advertisement|Remove ads.